Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
about
Cardiac cachexia: hic et nuncLoss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentGH and the cardiovascular system: an update on a topic at heartPharmacokinetics of drugs in cachectic patients: a systematic reviewMuscle wasting: an overview of recent developments in basic research.Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction.Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients.Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity.N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.New Approaches to Treating Cardiac Cachexia in the Older Patient.Cardiac Cachexia: Perspectives for Prevention and Treatment.A heart-adipose tissue connection in the regulation of energy metabolism.Malnutrition and Cachexia in Heart Failure.The interplay between heart failure, metabolism and body composition.Publication trends in cachexia and sarcopenia in elderly heart failure patients.Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.Sex Differences in Muscle Wasting.miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss.Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study.Muscle wasting and sarcopenia in heart failure and beyond: update 2017.Estimating fat mass in heart failure patients
P2860
Q26744140-1B513CBE-6F61-4232-8C74-BFE3E8330017Q26775254-74B29F74-693F-49CD-A275-2767C54C3327Q27002329-300371FF-B338-43F7-AFE7-E90B0B4F6813Q28535322-64746AD2-56F2-4EDB-BAC7-E19CB1A9CC36Q34156942-557FC437-BA89-4E9A-B0AC-C46BE53F9F61Q34591010-A9099460-E85B-4DAA-8A74-0A65A0473841Q34681621-89FDC88A-C5E3-4C7C-9744-B798274A03DCQ35003806-7AB1F45A-0872-4162-9188-C9B4CB05B7F8Q35049028-2DD1F610-C137-4629-BA2A-35FAD854EAF4Q35718443-60FEB6EA-A408-4632-81F7-D4DC303920C2Q36199888-CDCC1BAB-EC4F-4CCE-8994-513A3DACE102Q37523290-9F185F40-4CE4-4764-B958-02BAE6C38F42Q37594528-F20863C1-35A6-4FBD-ACE7-F203E079A9D0Q38168030-59B56835-1CD2-4B82-89CF-A3EE0A560D47Q38337032-4CC1BAEA-4380-44ED-A3C3-23203F0EE607Q38857371-52FEEC30-B59A-41FD-A56A-4171F494C67DQ39019268-4DCE8582-3EFF-42EA-BD53-3F53A30F151BQ44964814-6D67BE60-C63B-4D6B-9F49-167FB746C1D0Q47311543-25411379-AC40-48FE-9289-835D41DC759DQ47688387-A438C16D-72D6-4B91-A0D2-DA57E987EC75Q48746940-6412BCCE-8B2C-4265-9ACE-916DE0234018Q49183956-646538D5-79C3-4BE7-8A93-E9C837C8FCA9Q56964515-D642A151-A856-47F2-9F9B-8DBC5F07AE62
P2860
Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prevalence of cachexia in chro ...... position and metabolic status.
@en
Prevalence of cachexia in chro ...... position and metabolic status.
@nl
type
label
Prevalence of cachexia in chro ...... position and metabolic status.
@en
Prevalence of cachexia in chro ...... position and metabolic status.
@nl
prefLabel
Prevalence of cachexia in chro ...... position and metabolic status.
@en
Prevalence of cachexia in chro ...... position and metabolic status.
@nl
P2093
P2860
P50
P1433
P1476
Prevalence of cachexia in chro ...... position and metabolic status.
@en
P2093
Heidi Marie Christensen
Jan Frystyk
Jens Faber
Morten Schou
Niels Keller
P2860
P2888
P304
P356
10.1007/S12020-012-9836-3
P577
2012-11-22T00:00:00Z
P6179
1021246781